Log in
Enquire now
‌

US Patent 9035026 Anti-CD16 binding molecules

Patent 9035026 was granted and assigned to Affimed on May, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Affimed
Affimed
Date Filed
May 26, 2006
Date of Patent
May 19, 2015
Patent Application Number
11921123
Patent Citations Received
‌
US Patent 11987619 Single-chain chimeric polypeptides and uses thereof
0
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
‌
US Patent 12024545 Methods of treating aging-related disorders
0
‌
US Patent 11672826 Methods of treating aging-related disorders
0
‌
US Patent 11945869 PD-1 single domain antibodies and therapeutic compositions thereof
0
‌
US Patent 12018071 Single-chain chimeric polypeptides and uses thereof
0
‌
US Patent 11884712 Multi-chain chimeric polypeptides and uses thereof
0
Patent Inventor Names
Karin Hoffmann
0
Fabrice Le Gall
0
Melvyn Little
0
Sergey Kipriyanov
0
Stefan Knackmuss
0
Uwe Reusch
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9035026
Patent Primary Examiner
‌
Chun Dahle

Find more entities like US Patent 9035026 Anti-CD16 binding molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.